Log in
Enquire now
‌

US Patent 9597397 Formulations of bendamustine

Patent 9597397 was granted and assigned to Eagle Pharmaceuticals, Inc. on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc.
Current Assignee
Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9597397
Date of Patent
March 21, 2017
Patent Application Number
14857064
Date Filed
September 17, 2015
Patent Citations Received
‌
US Patent 11872214 Formulations of Bendamustine
0
Patent Primary Examiner
‌
Svetlana M Ivanova
Patent abstract

Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9597397 Formulations of bendamustine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.